LEFTY2
protein-codingleft-right determination factor 2, the group of Transforming growth factor beta superfamily
Gene summary
This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate the mature protein, which plays a role in left-right asymmetry determination of organ systems during development. The protein may also play a role in endometrial bleeding. Mutations in this gene have been associated with left-right axis malformations, particularly in the heart and lungs. Some types of infertility have been associated with dysregulated expression of this gene in the endometrium. This gene is closely linked to both a related family member and a related pseudogene. This gene encodes multiple isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Aug 2016]
- TGFB4
- EBAF
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~4.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0005453
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0018677
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0005453
Submitter: ClinGen
*LEFTY2* was first reported in relation to autosomal dominant congenital heart disease in 1999 (Kosaki et al., PMID: 10053005). Three variants (a missense, a nonsense, and a chromosomal segment deletion) that have been reported in three probands in two publications (PMIDs: 10053005, 25516202) are included in this curation. However, none were scored. The missense and nonsense mutations are too frequent in the general population, and the chromosomal segment deletion included other CHD-associated genes. The only experimental evidence, a mouse model, was not scored due to the lack of scorable genetic evidence and only a low portion of mice exhibiting cardiac anomalies (PMID: 11703930). In summary, the evidence supporting the relationship between *LEFTY2* and autosomal dominant congenital heart disease has been disputed and no valid evidence remains to support the claim. More evidence is needed to either support or entirely refute the role *LEFTY2* plays in this disease. This classification was approved by the ClinGen Congenital Heart Disease GCEP on the meeting date 2/6/2022 (SOP Version 10).
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Pulmonary
Intervention: Cardiovascular
Rationale: The condition can involve congenital cardiac anomalies, and awareness may allow early management
Comments: The contributions of variants to clinical disease are unclear
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to LEFTY2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_003240.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 54 | 5 | 62 | ||
| missense | 1 | 88 | 14 | 1 | 104 | |
| nonsense | 4 | 4 | ||||
| start loss | 0 | |||||
| frameshift | 2 | 2 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 0 | 1 | 98 | 68 | 6 | 173 |
Highest pathogenic variant AF is 0.00003407856
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_003231.2 | 4 | MANE Select | |
| Ensembl | ENSP00000355785.5 | 4 | MANE Select | |
| RefSeq | NP_001165896.1 | 5 | Standard | |
| Ensembl | ENSP00000388009.2 | 5 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| lft2 | Danio rerio | Structure: endodermal cell Quality: increased amount abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- TGF-beta signaling pathway - Homo sapiens (human)
- Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human)
- Cell Differentiation - Index expanded
- Cell Differentiation - Index
- Mesodermal Commitment Pathway
Biological Process
- platelet degranulation
- transforming growth factor beta receptor signaling pathway
- multicellular organism development
- regulation of signaling receptor activity
- positive regulation of pathway-restricted SMAD protein phosphorylation
Molecular Function
- cytokine activity
- transforming growth factor beta receptor binding
- growth factor activity
Cellular Component
- extracellular region
- extracellular space
- platelet alpha granule lumen
- collagen-containing extracellular matrix
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000366820
- Coding exons
- 4
- Length
- 4892
- Individuals with no LoFs
- 125699
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 18
- Defined
- 125717
- p
- 0.0000716
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.579 | 214 | 239 | 0.895 | 0.0000157 | 2302 |
| Missense (PolyPhen) | 43 | 65.797 | 0.65353 | 702 | ||
| Synonymous | -0.210 | 125 | 122 | 1.02 | 0.00000918 | 793 |
| Loss of Function | 1.72 | 8 | 15.2 | 0.525 | 8.29e-7 | 132 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00012 | 0.00011 | rare |
| South Asian | 0.00011 | 0.000098 | rare |
| Other | 0.00017 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Required for left-right (L-R) asymmetry determination of organ systems in mammals. May play a role in endometrial bleeding.;
- Disease
- DISEASE: Left-right axis malformations (LRAM) [MIM:601877]: The defect includes left pulmonary isomerism, with cardiac anomalies characterized by complete atrioventricular canal defect and hypoplastic left ventricle, and interrupted inferior vena cava. {ECO:0000269|PubMed:10053005}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.527
Intolerance Scores
- LoFtool
- 0.266
- RVIS EVS
- 0.33
- RVIS percentile EVS
- 73.27
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.307
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |